THE NORTH CENTRAL CANCER TREATMENT GROUP

本补助金申请的目的是支持马约诊所会员资格 北中央癌症治疗组（NCCTG） 马约诊所在其 在明尼苏达州的罗切斯特、佛罗里达的杰克逊维尔和 亚利桑那州的斯科茨代尔有足够的资源、人员、设施和病人 人口，以促进强大的贡献的研究计划， NCCTG。 在NCCTG成员中，它具有独特的能力， 初步研究，以提供治疗方案的耐受性/可行性数据， NCCTG全组II期和III期方案，以及相关的后续研究 与NCCTG癌症治疗方案相关的研究， 与来自马约诊所的实验室研究人员合作 综合癌症中心。 这项拨款建议的具体目的是 支持马约诊所参与NCCTG的以下方面 研究活动： 1.全组NCCTG癌症治疗方案的患者招募 2.提供背景临床数据的初步研究，以证明全组范围的合理性 NCCTG II期和III期癌症治疗方案 3.协调以实验室为基础的相关研究， 与NCCTG癌症治疗方案的关联。

The purpose of this grant application is to support Mayo Clinic membership in the North Central Cancer Treatment Group (NCCTG). Mayo Clinic at its three campuses in Rochester, Minnesota; Jacksonville, Florida; and Scottsdale, Arizona has the resources, personnel, facilities, and patient populations to facilitate strong contributions to the research programs of the NCCTG. Among NCCTG members it has the unique capability of conducting pilot studies to provide tolerability/feasibility data on regimens for NCCTG group-wide phase II and III protocols, and adjunctive correlative studies in association with NCCTG cancer treatment protocols through collaboration with laboratory investigators from the Mayo Clinic Comprehensive Cancer Center. The specific aims of this grant proposal are to support the following aspects of Mayo Clinic participation in NCCTG research activities: 1. Patient accrual to group-wide NCCTG cancer treatment protocols 2. Pilot studies to provide background clinical data to justify group-wide NCCTG phase II and III cancer treatment protocols 3. Coordination of adjunctive laboratory-based correlative studies in association with NCCTG cancer treatment protocols.